LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 358,592 Value ($000) $193 Avg Close — Range —
Q4 2024
Shares 627,321 Value ($000) $401 Avg Close — Range —
Q3 2024
Shares 832,323 Value ($000) $1,149 Avg Close — Range —
Q2 2024
Shares 349,017 Value ($000) $506 Avg Close — Range —
Q1 2024
Shares 425,675 Value ($000) $949 Avg Close — Range —
Q4 2023
Shares 627,695 Value ($000) $1,218 Avg Close — Range —
Q3 2023
Shares 537,617 Value ($000) $790 Avg Close — Range —
Q2 2023
Shares 656,023 Value ($000) $2,086 Avg Close — Range —
Q1 2023
Shares 555,530 Value ($000) $1,311 Avg Close — Range —
Q4 2022
Shares 1,212,574 Value ($000) $4,208 Avg Close — Range —
Q3 2022
Shares 385,220 Value ($000) $3 Avg Close — Range —
Q2 2022
Shares 201,407 Value ($000) $1 Avg Close — Range —
Q1 2022
Shares 186,356 Value ($000) $941 Avg Close — Range —
Q4 2021
Shares 104,112 Value ($000) $806 Avg Close — Range —
Q2 2021
Shares 202,034 Value ($000) $3,281 Avg Close — Range —